
Opinion|Videos|June 17, 2024
Epidemiology and Impact of Hidradenitis Suppurativa
Author(s)Iltefat Hamzavi, MD
An expert on hidradenitis suppurativa discusses the epidemiology of the disease and its profound impact on patients’ lives.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- What are some of the important epidemiological figures that are associated with hidradenitis suppurativa (HS) and how can clinicians incorporate these into their practices?
- How can this disease negatively impact patients’ lives?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
2
Making the Genetic Models Match the Ancestry of Patient Populations
3
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
4
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
5












































